| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 31-Dec-08 | | Total Revenue | 38,455 | 42,326 | 39,764 | 50,357 | | Cost of Revenue | 39,056 | 38,751 | 35,022 | 43,535 | | | Gross Profit | (601) | 3,575 | 4,742 | 6,822 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,875 | 7,653 | 7,817 | 8,083 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (7,476) | (4,078) | (3,075) | (1,261) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 48 | 48 | 81 | 11,653 | | Earnings Before Interest And Taxes | (7,428) | (4,030) | (2,994) | 10,392 | | Interest Expense | 953 | 906 | 950 | 995 | | Income Before Tax | (8,381) | (4,936) | (3,944) | 9,397 | | Income Tax Expense | (3,308) | (1,913) | (1,568) | 3,152 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,073) | (3,023) | (2,376) | 6,245 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,073) | (3,023) | (2,376) | 6,245 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,073) | ($3,023) | ($2,376) | $6,245 |
|
0.06% Nasdaq 
Income Statement
